Brainstorm Second Quarter 2022 Financial Results and Corporate Update Call
VirtualParticipant Numbers: Toll Free: 888-506-0062 International: 973-528-0011 Participant Access Code: 955552
Participant Numbers: Toll Free: 888-506-0062 International: 973-528-0011 Participant Access Code: 955552
AMX0035 (Amylyx Pharmaceuticals, Inc.) oral edaravone (Mitsubishi Tanabe Pharma Development America, Inc.) Given current data, AMX0035 is comparable or better to standard of care; AMX0035 would achieve common thresholds for cost-effectiveness if priced between $9,100 – $30,600 per year. Evidence indicates oral edaravone is comparable or incrementally better to standard of care; treatment would achieve […]
ALS Strategic Planning Workshop We would like to remind and encourage you to register for the virtual ALS Strategic Planning Workshop occurring this week on Wednesday October 26th and Thursday October 27th. A draft strategic plan of the highest priorities for research that will lead the way to the discovery of effective interventions for the diagnosis, treatment, management, prevention, or cure of […]
An informal conversation with the 2022 Award winners on their careers and their contributions to the field of ALS/MND. Panelists include Sally Light (Humanitarian Award recipient), Dr. Richard Bedlack (Forbes Norris Award recipient), Richard Cave (Allied Health Professional Award recipient).
n February 2023, the National Institute of Neurological Disorders and Stroke (NINDS), the lead institute for Amyotrophic Lateral Sclerosis (ALS) research within the National Institutes of Health (NIH), completed a strategic planning process to identify the highest priorities for research that will lead to the discovery of effective interventions for the diagnosis, treatment, management, prevention, […]
Patient Fellows Share Insights from 2024 ALS/MND Symposium Thursday, January 23, 2025 from 3:00 to 4:00 p.m. ET Participate in our upcoming Town Hall on January 23rd to hear from community members who attended the International Symposium on ALS/MND this past December. This event will feature Patient Fellows—individuals from the ALS community who were selected […]